Cusumano Ana Maria, Rosa-Diez Guillermo Javier, Gonzalez-Bedat Maria Carlota
Ana Maria Cusumano, CEMIC University Institute School of Medicine, Buenos Aires, PC C1430EFA, Argentina.
World J Nephrol. 2016 Sep 6;5(5):389-97. doi: 10.5527/wjn.v5.i5.389.
In 2015, 634387 million people (9% of the world's population) resided in Latin America (LA), with half of those populating Brazil and Mexico. The LA Dialysis and Transplant Registry was initiated in 1991, with the aim of collecting data on renal replacement therapy (RRT) from the 20 LA-affiliated countries. Since then, the Registry has revealed a trend of increasing prevalence and incidence of end-stage kidney disease on RRT, which is ongoing and is correlated with gross national income, life expectancy at birth, and percentage of population that is older than 65 years. In addition, the rate of kidney transplantation has increased yearly, with > 70% being performed from deceased donors. According to the numbers reported for 2013, the rates of prevalence, incidence and transplantation were (in patients per million population) 669, 149 and 19.4, respectively. Hemodialysis was the treatment of choice (90%), and 43% of the patients undergoing this treatment was located in Brazil; in contrast, peritoneal dialysis prevailed in Costa Rica, El Salvador and Guatemala. To date, the Registry remains the only source of RRT data available to healthcare authorities in many LA countries. It not only serves to promote knowledge regarding epidemiology of end-stage renal disease and the related RRT but also for training of nephrologists and renal researchers, to improve understanding and clinical application of dialysis and transplantation services. In LA, accessibility to RRT is still limited and it remains necessary to develop effective programs that will reduce risk factors, promote early diagnosis and treatment of chronic kidney disease, and strengthen transplantation programs.
2015年,6.34387亿人(占世界人口的9%)居住在拉丁美洲,其中一半人口分布在巴西和墨西哥。拉丁美洲透析与移植登记处成立于1991年,旨在收集来自20个拉丁美洲附属国家的肾脏替代治疗(RRT)数据。自那时以来,该登记处揭示了接受RRT的终末期肾病患病率和发病率不断上升的趋势,这一趋势仍在持续,且与国民总收入、出生时预期寿命以及65岁以上人口百分比相关。此外,肾脏移植率逐年上升,超过70%的移植手术是由已故捐赠者提供的肾脏进行的。根据2013年报告的数据,患病率、发病率和移植率分别为(每百万人口中的患者数)669、149和19.4。血液透析是首选治疗方法(90%),接受这种治疗的患者中有43%位于巴西;相比之下,腹膜透析在哥斯达黎加、萨尔瓦多和危地马拉更为普遍。迄今为止,该登记处仍是许多拉丁美洲国家医疗当局可获得的RRT数据的唯一来源。它不仅有助于促进对终末期肾病流行病学及相关RRT的了解,还用于培训肾病学家和肾脏研究人员,以提高对透析和移植服务的理解及临床应用。在拉丁美洲,获得RRT的机会仍然有限,仍有必要制定有效的项目,以降低风险因素,促进慢性肾病的早期诊断和治疗,并加强移植项目。